OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Showing 18 citing articles:
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 11
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 11
Comparative analysis of the genomic and expression profiles of ANLN and KDR as prognostic markers in breast Cancer
Aamir Mehmood, Rongpei Li, Aman Chandra Kaushik, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Aamir Mehmood, Rongpei Li, Aman Chandra Kaushik, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Understanding of chemotherapeutic resistance: With special reference to breast cancer
Harmanjit Singh, Dwividendra Kumar Nim, Pankaj Kumar, et al.
Elsevier eBooks (2025), pp. 173-206
Closed Access
Harmanjit Singh, Dwividendra Kumar Nim, Pankaj Kumar, et al.
Elsevier eBooks (2025), pp. 173-206
Closed Access
Molecular Docking Appraisal of Pleurotus ostreatus Phytochemicals as Potential Inhibitors of PI3K/Akt Pathway for Breast Cancer Treatment
Magdalene Eno Effiong, Mercy Bella-Omunagbe, Israel Sunmola Afolabi, et al.
Bioinformatics and Biology Insights (2025) Vol. 19
Open Access
Magdalene Eno Effiong, Mercy Bella-Omunagbe, Israel Sunmola Afolabi, et al.
Bioinformatics and Biology Insights (2025) Vol. 19
Open Access
Targeting PI3K/AKT/mTOR Signaling to Overcome Drug Resistance in Cancer
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 3
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 3
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer
Chiara Papulino, Ugo Chianese, Ahmad H. Ali, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Chiara Papulino, Ugo Chianese, Ahmad H. Ali, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Need for Genome specific personalized medicines in ORAL CANCER?
Chandrabose Selvaraj
Oral Oncology Reports (2024) Vol. 10, pp. 100276-100276
Open Access
Chandrabose Selvaraj
Oral Oncology Reports (2024) Vol. 10, pp. 100276-100276
Open Access
ZNAČAJ PRECIZNE MEDICINE I FARMAKOGENOMIKE U PREVENTIVNOJ PEDIJATRIJI
Ivana Kavečan, Nataša Nikolić, Đerđi Erdeš-Kavečan, et al.
Deleted Journal (2024), pp. 060-064
Open Access
Ivana Kavečan, Nataša Nikolić, Đerđi Erdeš-Kavečan, et al.
Deleted Journal (2024), pp. 060-064
Open Access
Personalized precision medicine for oral oncology
Rajiv Periakaruppan, K. T. Abhishekh, C. Nithya, et al.
Oral Oncology Reports (2024) Vol. 10, pp. 100301-100301
Open Access
Rajiv Periakaruppan, K. T. Abhishekh, C. Nithya, et al.
Oral Oncology Reports (2024) Vol. 10, pp. 100301-100301
Open Access
The Complex Connection between Obesity and Cancer: Signaling Pathways and Therapeutic Implications
Mohamed El‐Tanani, Syed Arman Rabbani, Alaa A. A. Aljabali, et al.
Nutrition and Cancer (2024) Vol. 76, Iss. 8, pp. 683-706
Closed Access
Mohamed El‐Tanani, Syed Arman Rabbani, Alaa A. A. Aljabali, et al.
Nutrition and Cancer (2024) Vol. 76, Iss. 8, pp. 683-706
Closed Access
Analysis of PIK3CA mutations in the primary and recurrent tumors of hormone receptor positive/human epidermal growth factor receptor 2 negative breast cancer
Yue Wang, Xin Li, Shuang Zhang, et al.
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 9, pp. 1024-1031
Closed Access
Yue Wang, Xin Li, Shuang Zhang, et al.
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 9, pp. 1024-1031
Closed Access
Enhancing breast cancer treatment through pharmacogenomics: A narrative review
Ram Mohan Ram Kumar, Suresh Joghee
Clinica Chimica Acta (2024) Vol. 562, pp. 119893-119893
Closed Access
Ram Mohan Ram Kumar, Suresh Joghee
Clinica Chimica Acta (2024) Vol. 562, pp. 119893-119893
Closed Access
Identification of breast cancer-associated PIK3CA H1047R mutation in blood circulation using an asymmetric PCR assay
Đinh Thị Thảo, Nguyen Phu Thanh, Đồng Văn Quyền, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0309209-e0309209
Open Access
Đinh Thị Thảo, Nguyen Phu Thanh, Đồng Văn Quyền, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0309209-e0309209
Open Access
The Role of Platelet-Rich Plasma in the Management of Sensorineural Hearing Loss: Current Evidence and Emerging Trends
C. Singh, Shraddha Jain
Cureus (2024)
Open Access
C. Singh, Shraddha Jain
Cureus (2024)
Open Access
Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine
Jelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1142-1142
Open Access
Jelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1142-1142
Open Access
Sparstolonin B Reduces Estrogen-Dependent Proliferation in Cancer Cells: Possible Role of Ceramide and PI3K/AKT/mTOR Inhibition
Yağmur Dilber, Tuğçe Çeker, Aleyna Öztüzün, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1564-1564
Open Access
Yağmur Dilber, Tuğçe Çeker, Aleyna Öztüzün, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1564-1564
Open Access
siRNA-based knockdown of lncRNAs; a new modality to target tumor progression
Abdulrahman Qais Khaleel, Saade Abdalkareem Jasim, Soumya V. Menon, et al.
Pathology - Research and Practice (2024) Vol. 266, pp. 155746-155746
Closed Access
Abdulrahman Qais Khaleel, Saade Abdalkareem Jasim, Soumya V. Menon, et al.
Pathology - Research and Practice (2024) Vol. 266, pp. 155746-155746
Closed Access
Exosome characterization techniques, composition analysis and contents of exosomes nanovesicles: Methods and interpretation
Pallavi Sandal, Sanchit Arora, Dalapathi Gugulothu
Elsevier eBooks (2024), pp. 105-127
Closed Access
Pallavi Sandal, Sanchit Arora, Dalapathi Gugulothu
Elsevier eBooks (2024), pp. 105-127
Closed Access
Golden eagle optimized CONV-LSTM and non-negativity-constrained autoencoder to support spatial and temporal features in cancer drug response prediction
Wesam Ibrahim Hajim, Suhaila Zainudin, Kauthar Mohd Daud, et al.
PeerJ Computer Science (2024) Vol. 10, pp. e2520-e2520
Open Access
Wesam Ibrahim Hajim, Suhaila Zainudin, Kauthar Mohd Daud, et al.
PeerJ Computer Science (2024) Vol. 10, pp. e2520-e2520
Open Access
Exploring the antiproliferative and proapoptotic activities of new pyridopyrimidine derivatives and their analogs
Hadeer M. Ali, Mohamed A. Said, Shady Allam, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 118, pp. 118053-118053
Closed Access
Hadeer M. Ali, Mohamed A. Said, Shady Allam, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 118, pp. 118053-118053
Closed Access